ZIEXTENZO 6 mg/.6mL
pegfilgrastim-bmez · INJECTION · Sandoz Inc
No Recall History
Plain English
ZIEXTENZO is a injection containing pegfilgrastim-bmez at 6 mg/.6mL, taken subcutaneous. Manufactured by Sandoz Inc.
Key Facts
- Brand Name
- ZIEXTENZO
- Generic Name
- pegfilgrastim-bmez
- NDC Code (Product)
61314-866- Manufacturer
- Sandoz Inc
- Strength
- 6 mg/.6mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761045
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 11/04/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is ZIEXTENZO used for?
ZIEXTENZO contains pegfilgrastim-bmez. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is ZIEXTENZO a controlled substance?
ZIEXTENZO is not classified as a controlled substance by the DEA.
What is the generic name for ZIEXTENZO?
The generic name for ZIEXTENZO is pegfilgrastim-bmez. There are no other listed brand versions of pegfilgrastim-bmez.
What is the NDC code for ZIEXTENZO 6 mg/.6mL?
The NDC (National Drug Code) for ZIEXTENZO 6 mg/.6mL is 61314-866, listed by Sandoz Inc.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)